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ardiotoxicity of antitumor drugs
iorgio Minotti
G. d’Annunzio University School of Medicine, 66013
hieti, Italy
ardiotoxicity is an untoward effect of many antitu-
or drugs. Fluoropyrimidines, taxanes, and alkylating
gents, may induce sporadic and dose-independent
schemia, arrhythmias, pericardial effusions; these are
ediated by impurities of the pharmaceutical com-
osition, unpredictable redox coupling of the drugs
ith myocardial electrophiles, hypersensitivity reac-
ions. Doxorubicin and other anthracyclines induce
concentration-dependent and irreversible cardiomy-
pathy that culminates in a congestive heart failure.
nthracycline cardiotoxicity, often referred to as “type
”, seems to develop in response to iron-mediated
xidative stress or metabolic perturbances mediated by
econdary alcohol metabolites. These concepts have
ormed the basis to design iron chelators that prevent car-
iotoxicity, or to develop anthracyclines that form fewer
mounts of their secondary alcohol metabolites.
Over the last few years several target-oriented drugs
ere developed with the aim of suppressing tumor
rowth while not causing side effects at cardiac or extrac-
rdiac sites. Some of these drugs (like the antiHER-2/neu
ntibody Trastuzumab) exhibited a new type of car-
iotoxicity that was referred to as “type II” and
as considered to be “mild” in the light of criteria
uch as reversibility and little or no recurrence upon
echallenge. However, combining Trastuzumab with
oxorubicin caused congestive heart failure at lower than
xpected cumulative doses of the anthracycline, as if the
ype II cardiotoxicity of Trastuzumab blocked survival
athways that mitigated the type I cardiotoxicity of dox-
rubicin. Many other targeted drugs might cause a type II
ardiotoxicity. This justifies an intensified and long-term
urveillance of the cardiac function of cancer patients
reated with anthracyclines and targeted drugs.
oi:10.1016/j.toxlet.2007.05.034
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Following the accident at the Chernobyl Nuclear Power
plant, a marked increase of various diseases was reported
in the literature. Several impairments of the cardio-
vascular system have been observed in children and
in liquidators but no experimental studies were under-
taken by the chronic contamination of animals at
post-accidental levels of cesium 137 (137Cs).
Biochemical, physiological and molecular markers
of the cardiovascular system were analysed in rats
exposed through drinking water to 137Cs at a dose of
500 Bq/kg (6500 Bq/l). Plasma concentration of CK and
CK-MB, biochemical markers of cardiac damage, were
higher (>52%, p < 0.05) in contaminated rats whereas
no histological alteration of the heart appeared. Nev-
ertheless, small modifications of heart gene expression
were observed in the atria. Angiotensin converting
enzyme (ACE), the rate-limiting enzyme of the renin-
angiotensin system, and brain natriurectic peptide
(BNP), involved in physiological regulation of blood
pressure, were significantly increased (p < 0.05). ECG
and blood pressure measurement were then undertaken
to analyse if there were any physiological consequences.
No arrhythmia was observed except ST- and RT-segment
depression (−9% and −11%, respectively, p < 0.05) in
rats exposed to 137Cs. Furthermore, mean arterial blood
pressure decreased (−10%, p < 0.05) in 137Cs-exposed
rats along with a disappearance of the blood pressure
circadian rhythm.
Overall, chronic contamination with a post-accidental
dose of 137Cs during 3 months did not result in patholog-
ical disorder, but the impairments of the cardiovascular
system observed could evolve to more significant alter-
ation in sensitive animals or after a longer contamination.
doi:10.1016/j.toxlet.2007.05.035
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The sustained elevation of plasma and interstitial cate-
cholamine levels, namely adrenaline (ADR), in several
pathologic conditions raises many questions in the cel-
lular toxicity that those compounds can undertake.
Additionally, when an ischemic/reperfusion feature is
present, a burst of reactive species of oxygen (ROS)
occurs. In the present study, we investigated the role of
ROS production on the activation of transcription fac-
tors in freshly isolated adult rat cardiomyocytes exposed
to ADR. Furthermore, the cardiomyocytes were also
exposed to ADR with a system capable of generat-
ing ROS [xanthine and xanthine oxidase (X/XO)]. ROS
production was measured with the fluorescent 123-
dihydrorhodamine dye during 3 h. The levels of ROS,
when compared with control cells, largely and rapidly
increased in the ADR plus X/XO cells, while in ADR
group, it rose more gradually. Heat shock factor-1 (HSF-
1) was the foremost transcription factor detected during
the incubation time by electrophoretic mobility shift
assay, first in the cardiomyocytes exposed to ADR plus
X/XO and afterwards in the cardiomyocytes exposed
to ADR alone. The activation of nuclear factor kappaB
(NF-B) followed the same time pattern, with onset in a
longer incubation period. These results suggest that NF-
B transient activation in cardiomyocytes occurs when
a threshold of ROS in the cells is reached, after which
the activation signal is interrupted, while the activation of
HSF occurred even before any differences were observed
in ROS levels.
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Alternative approaches to immunotoxicity and
allergy testing
Andre´ Penninks
TNO, Zeist, The Netherlands
For the evaluation of potential immunotoxicity/
allergenicity of test materials (drugs, food ingredients/
additives and industrial chemicals) in vivo testing
is currently most relevant, especially because of the
complexicity of the immune system including many dif-
ferent cell types, receptor interactions and signalling172S (2007) S1–S240
molecules. Despite this problem it is desirable also in this
field of immunotoxicity/allergenicity testing to reduce,
refine and replace the use of animals. Therefore the
development, validation and acceptance of new in vitro
alternatives for immunotoxicity and allergenicity test-
ing (respiratory-, food and contact hypersensitivity) are
needed. In particular in respect to for instance the imple-
mentation of the Registration, Evaluation and Authorisa-
tion of new and existing Chemicals (REACH) alternative
in vitro/in silico testing methods and assessment strate-
gies would be of importance to reduce laboratory use.
The objective of this presentation is to overview sev-
eral approaches to in vitro immunotoxicity and allergy
research as are presented in literature or subject of current
research projects.
From the various in vitro approaches in respect to
immunotoxicity and allergenicity testing it is evident
that a lot of additional information can be obtained by
using various types of cells such as lymphocytes, den-
dritic cells/langerhans cells, basophiles, etc., which also
can be obtained from different species. However, it is
also obvious that not for all interactions of immunotoxic
compounds with the immune system in vitro methods
can be easily developed like, e.g. for autoimmunity
and immune stimulation. Overall the in vitro tests are
extremely valuable for studying the molecular mecha-
nism of action of immunotoxic/allergic compounds on
target immune cells. It is evident, however, that in most
situations in vitro alternatives only cover specific parts of
the immunotoxic/allergic process and that in many cases
they only can be used in conjunction with other data.
Therefore, it is clear that despite the significant progress
that is made with in vitro immunotoxicity/allergenicity
testing still a lot of research is needed before in vitro
tests will indeed be able to replace (in part) in vivo
immunotoxicity/allergenicity testing.
doi:10.1016/j.toxlet.2007.05.038
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